Clinical lung cancer
Actionable Gene Alterations in Resected Non-Small Cell Lung Cancer: Primary Results From the AGA-R Study.
Ilaria Attili, Gloria Pellizzari, Luca Bertolaccini, Carla Corvaja, Davide Vacirca, Mariano Lombardi, Gianluca Spitaleri, Pamela Trillo Aliaga, Ester Del Signore, Antonio Passaro, Juliana Guarize, Elena Guerini-Rocco, Nicola Fusco, Lorenzo Spaggiari, Filippo de Marinis
Published: 202510.1016/j.cllc.2025.09.015
Abstract
INTRODUCTION: In resected non-small cell lung cancer (NSCLC), molecular testing is currently limited to EGFR mutations and ALK rearrangements, as these guide approved adjuvant therapies. The role of next-generation sequencing (NGS), routinely used in…
Preview only. Read the full abstract at the source